Clinical Trial Update: A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis B [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of peginterferon alfa-2b and GM-CSF for chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• Peginterferon alfa-2b (Peginterferon alfa-2b)

Snippet

Sponsor: Xiamen Amoytop Biotech Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED